As Mylan Nv F (MYL) Shares Declined, Regent Investment Management Raised by $1.52 Million Its Holding; As Colgate Palmolive Co (CL) Stock Declined, Holder Provise Management Group Lowered Position

May 21, 2018 - By Louis Casey

Mylan N.V. (NASDAQ:MYL) Logo

Regent Investment Management Llc increased its stake in Mylan Nv F (MYL) by 178.38% based on its latest 2017Q4 regulatory filing with the SEC. Regent Investment Management Llc bought 36,185 shares as the company’s stock declined 5.99% with the market. The hedge fund held 56,470 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $2.39M, up from 20,285 at the end of the previous reported quarter. Regent Investment Management Llc who had been investing in Mylan Nv F for a number of months, seems to be bullish on the $20.52 billion market cap company. The stock increased 0.35% or $0.14 during the last trading session, reaching $39.8. About 972,817 shares traded. Mylan N.V. (NASDAQ:MYL) has declined 5.23% since May 21, 2017 and is downtrending. It has underperformed by 16.78% the S&P500.

Provise Management Group Llc decreased its stake in Colgate Palmolive Co (CL) by 22.37% based on its latest 2017Q4 regulatory filing with the SEC. Provise Management Group Llc sold 4,475 shares as the company’s stock declined 7.81% with the market. The institutional investor held 15,529 shares of the package goods and cosmetics company at the end of 2017Q4, valued at $1.17M, down from 20,004 at the end of the previous reported quarter. Provise Management Group Llc who had been investing in Colgate Palmolive Co for a number of months, seems to be less bullish one the $54.43 billion market cap company. The stock increased 0.29% or $0.18 during the last trading session, reaching $62.4. About 1.79 million shares traded. Colgate-Palmolive Company (NYSE:CL) has declined 5.65% since May 21, 2017 and is downtrending. It has underperformed by 17.20% the S&P500.

Among 25 analysts covering Colgate-Palmolive (NYSE:CL), 5 have Buy rating, 1 Sell and 19 Hold. Therefore 20% are positive. Colgate-Palmolive had 70 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Tuesday, February 21 by BNP Paribas. The firm earned “Sell” rating on Wednesday, November 29 by Societe Generale. RBC Capital Markets maintained it with “Hold” rating and $74.0 target in Friday, October 6 report. The firm has “Hold” rating given on Tuesday, April 17 by Stifel Nicolaus. RBC Capital Markets maintained the stock with “Hold” rating in Tuesday, September 5 report. The rating was maintained by RBC Capital Markets with “Hold” on Friday, May 26. As per Monday, January 18, the company rating was upgraded by BNP Paribas. The company was maintained on Friday, November 10 by RBC Capital Markets. On Monday, September 25 the stock rating was upgraded by Morgan Stanley to “Overweight”. On Monday, September 12 the stock rating was upgraded by Bank of America to “Buy”.

Investors sentiment decreased to 0.87 in 2017 Q4. Its down 0.03, from 0.9 in 2017Q3. It turned negative, as 56 investors sold CL shares while 444 reduced holdings. 98 funds opened positions while 335 raised stakes. 606.34 million shares or 1.77% less from 617.24 million shares in 2017Q3 were reported. Alphaone Invest Service Lc stated it has 2,721 shares. Weik Cap Mgmt invested in 0.21% or 5,982 shares. Associated Banc owns 105,702 shares or 0.43% of their US portfolio. Old Second National Bank & Trust Of Aurora accumulated 0.04% or 1,474 shares. The Pennsylvania-based Veritable Limited Partnership has invested 0.07% in Colgate-Palmolive Company (NYSE:CL). Windsor Cap Management Limited Liability Corp reported 3,985 shares. Ameritas Investment Prns invested 0.08% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Chevy Chase Tru Hldg reported 0.26% in Colgate-Palmolive Company (NYSE:CL). Wheatland Advsrs Inc invested 0.42% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Cambridge Trust Com has invested 0.02% in Colgate-Palmolive Company (NYSE:CL). Parsons Capital Inc Ri reported 0.15% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Cap Advsr Ltd Limited Liability invested in 0.01% or 370 shares. Pacific Glob Invest Management Comm holds 14,920 shares. Duff & Phelps Management reported 9,710 shares. Massachusetts-based Btim Corp has invested 0.65% in Colgate-Palmolive Company (NYSE:CL).

More news for Colgate-Palmolive Company (NYSE:CL) were recently published by: Seekingalpha.com, which released: “Colgate-Palmolive: A Consumer Defensive Heavyweight” on May 14, 2018. Benzinga.com‘s article titled: “Morgan Stanley Shifts To Neutral On Colgate-Palmolive, Cites Emerging Markets Weakness” and published on April 30, 2018 is yet another important article.

Provise Management Group Llc, which manages about $1.14B and $697.04 million US Long portfolio, upped its stake in United Technologies Corp (NYSE:UTX) by 6,673 shares to 61,424 shares, valued at $7.84 million in 2017Q4, according to the filing. It also increased its holding in Ishares Tr (EFAV) by 8,029 shares in the quarter, for a total of 158,490 shares, and has risen its stake in Schwab Strategic Tr (SCHV).

Since December 13, 2017, it had 0 insider purchases, and 25 insider sales for $43.37 million activity. 4,161 shares valued at $292,026 were sold by Skala Justin on Tuesday, February 20. Shares for $705,797 were sold by MOISON FRANCK J on Wednesday, February 7. Marsili Daniel B sold 19,500 shares worth $1.20 million. $2.85 million worth of Colgate-Palmolive Company (NYSE:CL) was sold by Wallace Noel R.. 7,000 Colgate-Palmolive Company (NYSE:CL) shares with value of $435,600 were sold by Gayle Helene D. $2.58 million worth of Colgate-Palmolive Company (NYSE:CL) shares were sold by JAKOBSEN HENNING I.

Analysts await Colgate-Palmolive Company (NYSE:CL) to report earnings on July, 20. They expect $0.79 earnings per share, up 9.72% or $0.07 from last year’s $0.72 per share. CL’s profit will be $689.14 million for 19.75 P/E if the $0.79 EPS becomes a reality. After $0.74 actual earnings per share reported by Colgate-Palmolive Company for the previous quarter, Wall Street now forecasts 6.76% EPS growth.

Investors sentiment increased to 3 in Q4 2017. Its up 2.67, from 0.33 in 2017Q3. It increased, as 0 investors sold MYL shares while 1 reduced holdings. 3 funds opened positions while 0 raised stakes. 292,846 shares or 88.91% more from 155,019 shares in 2017Q3 were reported. Moreover, Gulf International National Bank (Uk) Limited has 0.08% invested in Mylan N.V. (NASDAQ:MYL) for 139,930 shares. Van Hulzen Asset Limited Liability Corp holds 120,545 shares or 1.55% of its portfolio. 17,231 are held by Mirae Asset Invs Limited. Vantage Investment Limited Liability holds 0% or 337 shares.

Among 22 analysts covering Mylan Inc. (NASDAQ:MYL), 16 have Buy rating, 0 Sell and 6 Hold. Therefore 73% are positive. Mylan Inc. had 74 analyst reports since July 27, 2015 according to SRatingsIntel. The firm earned “Equal-Weight” rating on Friday, October 6 by Morgan Stanley. The stock of Mylan N.V. (NASDAQ:MYL) earned “Buy” rating by Deutsche Bank on Friday, August 7. The firm has “Buy” rating by Mizuho given on Thursday, April 12. The company was maintained on Tuesday, September 6 by RBC Capital Markets. The firm earned “Buy” rating on Friday, November 18 by Mizuho. The firm earned “Buy” rating on Wednesday, October 26 by Mizuho. The stock has “Buy” rating by Argus Research on Friday, August 7. The firm has “Buy” rating given on Thursday, January 25 by Susquehanna. The firm earned “Market Perform” rating on Friday, February 19 by Wells Fargo. On Saturday, August 29 the stock rating was maintained by Leerink Swann with “Outperform”.

Regent Investment Management Llc, which manages about $294.77 million and $304.82M US Long portfolio, decreased its stake in Merck & Co Inc (NYSE:MRK) by 17,359 shares to 42,495 shares, valued at $2.39M in 2017Q4, according to the filing. It also reduced its holding in Mondelez Intl Class A (NASDAQ:MDLZ) by 8,738 shares in the quarter, leaving it with 17,821 shares, and cut its stake in Humana Inc (NYSE:HUM).

Colgate-Palmolive Company (NYSE:CL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Louis Casey

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: